Selected References:
- Cahill JB, et al. 2005. Levofloxacin secretion in breast milk: a case report. Pharmacotherapy, 25(1):116–118.
- Giamarellou H, et al. 1989. Pharmacokinetics of three newer quinolones in pregnant and lactating women. The American journal of medicine, 87(5A):49S–51S.
- Gürpinar AN, et al. 1997. The effects of a fluoroquinolone on the growth and development of infants. The Journal of international medical research, 25(5):302–306.
- Meaney-Delman D, et al. 2013. Prophylaxis and treatment of anthrax in pregnant women. Obstetrics and gynecology, 122(4):885–900.
- Padberg S, et al. 2014. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones. Antimicrobial agents and chemotherapy, 58(8):4392–4398.
- Shang J, et al. 2025. An Observational Study on the Pharmacokinetics of Levofloxacin in Lactating Atypical Pneumonia Patients. Breastfeed Med; 20(9):666-671.
- Toker SE, et al. 2021. Determination of levofloxacin by HPLC with fluorescence detection in human breast milk. Bioanalysis, 13(13):1063–1070.
- van den Oever HL, et al. 1998. Ciprofloxacin in preterm neonates: case report and review of the literature. European journal of pediatrics; 157(10):843–845.
